Plasminogen activator system in smokers and non-smokers with and without periodontal disease.

BACKGROUND The present study assessed levels of plasminogen activator (PA) system proteins in gingival crevicular fluid (GCF) and serum of chronic gingivitis, chronic periodontitis patients and periodontally healthy subjects and evaluated how smoking influenced these levels. METHODS Twenty chronic gingivitis; 20 chronic periodontitis patients and 20 periodontally healthy volunteers were consecutively recruited according to the inclusion criteria so that exactly half of the subjects in each category were smokers. GCF samples from four sites together with serum samples were obtained from each subject. GCF levels of tissue type PA (t-PA), urokinase type PA (u-PA), PA inhibitor-1 (PAI-1) and PA inhibitor-2 (PAI-2) and serum concentrations of cotinine, u-PA and PAI-1 were analysed by enzyme-linked immunosorbent assay. RESULTS The only statistically significant difference between smokers and non-smokers was a lower GCF PAI-2 concentrations in healthy smokers compared with healthy non-smokers (p<0.01). Gingivitis and periodontitis patients had higher GCF concentrations of PAI-2 than healthy subjects (p<0.002 and p<0.02 respectively). The ratio of u-PA:PAI-1 and t-PA:PAI-1 were significantly higher in GCF of smokers with periodontitis compared with "healthy" smokers, whereas the ratio of t-PA:PAI-2 was significantly lower in smokers with periodontal disease (p<0.05). CONCLUSIONS GCF levels of the PA system proteins are increased in chronic gingivitis and periodontitis compared with healthy gingiva. Smoking had only subtle effects on the GCF PA system proteins with the exception of PAI-2, and the balance of activators and inhibitors. These findings suggest one mechanism whereby smoking may exert detrimental effects on the periodontal tissues.

[1]  T. Köse,et al.  Periodontal infections and pre-term low birth weight: a case-control study. , 2005, Journal of clinical periodontology.

[2]  N. Buduneli,et al.  Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients. , 2004, Journal of clinical periodontology.

[3]  G. K. Johnson,et al.  Cigarette smoking and the periodontal patient. , 2004, Journal of periodontology.

[4]  J. Lindholt,et al.  Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[5]  J. Echeverría,et al.  Effects of smoking on periodontal tissues. , 2002, Journal of clinical periodontology.

[6]  D. Webb,et al.  Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man. , 2001, Cardiovascular research.

[7]  F. Eggert,et al.  Effects of smoking and treatment status on periodontal bacteria: evidence that smoking influences control of periodontal bacteria at the mucosal surface of the gingival crevice. , 2001, Journal of periodontology.

[8]  P. Bartold,et al.  Detection of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2(PAI-2) in gingival crevicular fluid from healthy, gingivitis and periodontitis patients. , 2000, Journal of clinical periodontology.

[9]  L. Matsson,et al.  Localization of plasminogen activators and plasminogen-activator inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization. , 1999, Archives of oral biology.

[10]  J. Bergström,et al.  Smoking and crevicular fluid levels of IL-6 and TNF-alpha in periodontal disease. , 1999, Journal of clinical periodontology.

[11]  B. Nielsen,et al.  Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[12]  J. Bergström,et al.  Influence of smoking on the outcome of periodontal surgery. A 5-year follow-up. , 1998, Journal of clinical periodontology.

[13]  G. Dahlén,et al.  The clinical and microbiological effects of non-surgical periodontal therapy in smokers and non-smokers. , 1998, Journal of clinical periodontology.

[14]  R. Hirsch,et al.  The effects of local anesthetic containing adrenaline on gingival blood flow in smokers and non-smokers. , 1997, Journal of clinical periodontology.

[15]  N. Booth,et al.  THE EFFECTS OF CHRONIC SMOKING ON THE FIBRINOLYTIC POTENTIAL OF PLASMA AND PLATELETS , 1997, British journal of haematology.

[16]  N. Sun,et al.  Chronic Nicotine Treatment Enhances Focal Ischemic Brain Injury and Depletes Free Pool of Brain Microvascular Tissue Plasminogen Activator in Rats , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  L. Matsson,et al.  Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. , 1996, Journal of periodontal research.

[18]  K. Winther,et al.  Smoking further increases platelet activity in patients with mild hypertension , 1996, European journal of clinical investigation.

[19]  M. Baker,et al.  Biological and clinical aspects of plasminogen activator inhibitor type 2. , 1995, Blood.

[20]  J. Brown,et al.  Molecular characterization of plasminogen activators in human gingival crevicular fluid. , 1995, Archives of oral biology.

[21]  R. Grimble,et al.  Cigarette smoking influences cytokine production and antioxidant defences. , 1995, Clinical science.

[22]  J. Wennström,et al.  Acute-phase proteins and immunoglobulin G against Porphyromonas gingivalis in peri-implant crevicular fluid: a comparison with gingival crevicular fluid. , 1995, Clinical oral implants research.

[23]  L. Matsson,et al.  The plasminogen-activating system in gingival fluid from adults. An intra-individual study before and after treatment of gingivitis. , 1994, Scandinavian journal of dental research.

[24]  G. Koch,et al.  Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. , 1994, Journal of periodontology.

[25]  G. K. Johnson,et al.  The effect of smoking on the response to periodontal therapy. , 1994, Journal of clinical periodontology.

[26]  L. Granath,et al.  Tissue plasminogen activator (t-PA) and placental plasminogen activator inhibitor (PAI-2) in gingival fluid from 8-9-year-old children. , 1993, Scandinavian journal of dental research.

[27]  J. Bergström,et al.  Occurrence of periopathogens in smoker and non-smoker patients. , 1992, Journal of clinical periodontology.

[28]  R. Page,et al.  Host Response Tests for Diagnosing Periodontal Diseases. , 1992, Journal of periodontology.

[29]  B. Åstedt,et al.  Tissue plasminogen activator and placental plasminogen activator inhibitor in human gingival fluid , 1991 .

[30]  W. Haire,et al.  Abnormal fibrinolysis in healthy male cigarette smokers: Role of plasminogen activator inhibitors , 1989, American journal of hematology.

[31]  M. Curtis,et al.  The total protein concentration of gingival crevicular fluid. Variation with sampling time and gingival inflammation. , 1988, Journal of clinical periodontology.

[32]  I. Hägerstrand,et al.  Cellular Localisation in Placenta of Placental Type Plasminogen Activator Inhibitor , 1986, Thrombosis and Haemostasis.

[33]  A. Kjaeldgaard,et al.  Long‐Term Treatment with Combined Oral Contraceptives and Cigarette Smoking Associated with Impaired Activity of Tissue Plasminogen Activator , 1986, Acta obstetricia et gynecologica Scandinavica.

[34]  O. Saksela,et al.  Plasminogen activation and regulation of pericellular proteolysis. , 1985, Biochimica et biophysica acta.

[35]  C. Kluft,et al.  Acute effect of smoking on fibrinolysis: increase in the activity level of circulating extrinsic (tissue‐type) plasminogen activator* , 1984, European journal of clinical investigation.

[36]  L. Ossowski,et al.  Antibodies to plasminogen activator inhibit human tumor metastasis , 1983, Cell.

[37]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[38]  H. Löe,et al.  PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. , 1964, Acta odontologica Scandinavica.

[39]  T. F. Walsh,et al.  Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. , 2003, Journal of clinical periodontology.

[40]  L. Matsson,et al.  Plasminogen activating capacity in gingival fluid from deteriorating and stable periodontal pockets. , 2002, Journal of periodontal research.

[41]  I. Chestnutt,et al.  Smoking and periodontal disease. , 2000, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[42]  G. Koch,et al.  Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. , 1995, Journal of periodontology.

[43]  R. Kent,et al.  Evidence for cigarette smoking as a major risk factor for periodontitis. , 1993, Journal of periodontology.

[44]  E. Kruithof,et al.  Plasminogen activator inhibitors--a review. , 1988, Enzyme.

[45]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.